Skip to main content

Table 1 Characteristics of patients with and without coronary dilatation during their acute KD phase

From: Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease

  All (169) Normal (138) Dilatation (31) P value
Male gender 99 (59%) 81 (59%) 18 (58%) 0.949
Age (yr) 1.44 (0.67; 2.56) 1.46 (0.71; 2.74) 1.12 (0.36; 2.09) 0.063
IVIG unresponsive 20 (12%) 11 (8%) 9 (29%) 0.001
Days of fever before IVIG use 5 (5; 6) 5 (4.3; 6) 5 (5; 6.3) 0.518
Albumin (g/dL) 3.9 (3.5; 4.3) 4 (3.6; 4.3) 3.5 (3.2; 4.2) 0.03
AST (U/L) 38 (29; 66.5) 37 (29; 71.5) 39.5 (25.3; 56.3) 0.379
CRP (mg/dL) 7.23 (2.22; 14.15) 6.1 (3.26; 11.93) 14.05 (6.38; 18.29) 0.009
WBC (k/μL) 13.74 (10.32; 17.56) 13.61 (10.29; 16.94) 15.36 (10.74; 19.64) 0.418
 Seg (%) 62.3 (51.3; 73.6) 62.9 (53.5; 73.9) 59 (49.7; 72) 0.391
Hb (g/dL) 11.1 (10.4; 12) 11.2 (10.5; 12) 10.9 (10.4; 11.8) 0.329
PLT (k/μL) 333 (260; 412) 328 (260; 405) 343 (253; 454) 0.285
  1. Values are expressed as medians (IQRs) and percentages (%). IVIG intravenous immunoglobulin, AST Aspartate aminotransferase, CRP C-reactive protein, WBC White blood cell, Seg Neutro segment WBC, Hb hemoglobin, PLT platelet